Lv4
700 积分 2024-10-23 加入
Steatotic Liver Disease‐Related Polygenetic Risk Score Prediction of Hepatocellular Carcinoma in Nucleotide/Nucleoside Analog‐Treated Chronic Hepatitis B
15天前
已完结
Incidences and Determinants of Functional Cure During Entecavir or Tenofovir Disoproxil Fumarate for Chronic Hepatitis B
15天前
已完结
Impact of liver steatosis on antiviral effects of pegylated interferon-alpha in patients with chronic hepatitis B
15天前
已完结
Impact of nonalcoholic fatty liver disease status change on antiviral efficacy of nucleos(t)ide analogues in HBeAg‐positive chronic hepatitis B
17天前
已完结
Impact of Non‐Alcoholic Fatty Liver Disease on the HBsAg Loss of Patients With Chronic Hepatitis B Treated in Pegylated Interferon Alpha
17天前
已完结
Effect of Hepatosteatosis on the Virological Response in Entecavir and Tenofovir Therapies
19天前
已完结
Chronic hepatitis B virus infection with nonalcoholic fatty liver disease:Problems faced by antiviral therapy
24天前
已关闭
Impact of liver steatosis on antiviral effects of pegylated interferon-alpha in patients with chronic hepatitis B
1个月前
已完结
Impact of liver steatosis on antiviral effects of pegylated interferon-alpha in patients with chronic hepatitis B
1个月前
已关闭
High value of controlled attenuation parameter predicts a poor antiviral response in patients with chronic hepatits B
1个月前
已完结
皖公网安备34019202002308
